• Leveraging electrochemical biosensor technology platform to drive growth across multiple industries
• Addressing challenges and issues faced in 2024, including new sales team, distribution strategies, and product launches
• Providing business updates on key product lines - Sentia, Xprecia, Petrackr, and HRL

Universal Biosensors (ASX:UBI) is a world leader in electrochemical cell technology that has developed portable, handheld, high performance liquid testing products in different market segments. The company is now focused on commercialisation and driving significant sales growth across all markets, including blood testing, wine testing, veterinary testing, and water testing. UBI's corporate strategy is to leverage the existing and proven electrochemical biosensor technology platform to drive growth across multiple industries and applications. This includes expanding the use of the technology platform to new opportunities in the future.The presentation addressed various challenges and issues faced by UBI in 2024, such as new sales leadership, unsuccessful distribution strategies, regulatory delays, and product performance issues. However, the company has resolved many of these challenges and is seeing positive momentum, with Q1 2025 sales up 6% year-on-year.The update provided details on the performance and outlook for UBI's key product lines:- Sentia, the world's first portable wine analyzer, saw 32% growth in Q1 2025. UBI is focused on accelerating device adoption and increasing usage across all markets.- Xprecia, the blood testing product for monitoring coagulation, faced a 9% decline in Q1 2025 due to the loss of a customer, but UBI is targeting new tender business and partnerships to drive growth.- Petrackr, the veterinary blood glucose monitoring product, grew 168% in Q1 2025, and UBI is pursuing direct-to-consumer and e-commerce channels.- HRL, UBI's blood testing laboratory, is a strategic asset for calibrating products, and the company is focused on re-engaging with customers and securing new business.Overall, the presentation highlighted UBI's focus on leveraging its core technology platform to drive growth across multiple industries, while addressing past challenges and pursuing new opportunities.